Navigation Links
Certain bacteria suppress production of toxic shock toxin: Probiotic potential looms
Date:3/22/2013

Certain Streptococci increase their production of toxic shock syndrome toxin 1, sometimes to potentially dangerous levels, when aerobic bacteria are present in the vagina. But scientists from the University of Western Ontario have discovered certain strains of lactobacillus bacteria are capable of dampening production of that toxin according to research published in the journal Applied and Environmental Microbiology.

"The risk of potentially fatal toxic shock syndrome appears to be influenced by the types of bacteria present in the vagina," says principal investigator Gregor Reid.

In planning the study, "I figured that the Staphylococcus aureus strains with the ability to produce toxic shock syndrome toxin might only do this under certain environmental conditions," says Reid. "In the vagina, that means depending on pH and the other bacteria living there."

The researchers took swabs from women with clinically healthy vaginal status, with intermediate status, and from those diagnosed with bacterial vaginosis. They then identified the bacterial species, and assayed for toxic shock syndrome toxin 1. "In particular, Streptococcus agalactiae, often referred to as Group B streptococci, an organism of particular concern when giving birth, increased toxin production 3.7-fold," says Reid. But various species of lactobacillus repressed toxin production, one by 72 percent.

"These experiments emphasize that for proper clinical care of women, we need to know all bacterial types present in the vagina," says Reid. "Culturing is inadequate, and while some microscopy is feasible if the viewer develops the expertise to assess the vaginal smears, rapid 16s sequencing systems are needed as a diagnostic tool," because many species are "very difficult to culture," or have never been cultured.

"We need to vastly improve how we diagnose infections and determine the risk of infection of women," says Reid. He also recommends "improving our ability to manipulate microbiota [with probiotics] in lieu of using broad spectrum antibiotics that were developed 40 years ago, and are not very effective in the vagina, and certainly not designed to neutralize toxins."


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related medicine news :

1. With Certain Strokes, Effects Can Persist a Decade Later
2. Video game exercise for an hour a day may enhance certain cognitive skills
3. Certain Men May Face Higher Risk of Brain Injury
4. Certain Diabetes Medications May Lower Heart Failure Risk
5. Certain Sleep Aids May Raise Hip Fracture Risk in Nursing Homes: Study
6. Obesity, physical inactivity linked with risk for certain molecular subtype of colorectal cancer
7. Codeine Risky for Kids After Certain Surgeries, FDA Says
8. The science of uncertainty in genomic medicine
9. USC research finds certain contraceptive may pose risk of Type 2 diabetes for obese women
10. Certain Skin Cancers More Common in HIV-Positive People
11. Certain Jobs May Still Pose Risk for Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... Quorum Health announced ... Resources (QHR). At the same time, John Maher was promoted to COO of QHR. ... the retirement of Mickey Bilbrey, former president and CEO in December 2016. ...
(Date:6/28/2017)... ... June 28, 2017 , ... Guide to FDA and EU Medical Device ... on which side of the Atlantic devicemakers do business, this fully updated and expanded ... , In addition to the full text of the FDA’s regulations in 21 CFR ...
(Date:6/28/2017)... Orland Park, IL (PRWEB) , ... June 28, 2017 , ... David B. Sosin, ... in Orland Park, Illinois, took over the post of 2nd Vice President for the ... , Sosin was installed as the ISBA’s 3rd Vice President in 2016 following a state-wide ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) ... year study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium ... brine-impacted groundwater. As a part of the study, batch adsorption experiments were conducted ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
(Date:5/23/2017)... 2017  Leaf Healthcare, recognized for developing one ... pressure ulcer prevention, will unveil its comprehensive mobility ... Care Nurses, National Teaching Institute and Critical Care ... Leaf Patient Monitoring System is the first mobility ... The system seamlessly tracks patient movement throughout the ...
Breaking Medicine Technology: